HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.

AbstractBACKGROUND AND PURPOSE:
Betulinic acid, a pentacyclic triterpene, is a new cytotoxic compound active on melanoma, neuroblastoma, glioblastoma and head and neck squamous cell carcinoma (HNSCC) cells. In combination with irradiation it has been shown to have an additive effect on growth inhibition in melanoma cells. In this study, the radiosensitizing effect of betulinic acid on sequential irradiation was investigated in HNSCC cell lines.
MATERIAL AND METHODS:
Two HNSCC cell lines, SCC9 and SCC25, were treated with increasing doses of betulinic acid and sequentially irradiated with a single boost of 4 Gy from a conventional radiation source. The cells were counted, the surviving fraction was determined, and colony-forming assays were performed.
RESULTS:
It could be shown that betulinic acid alone inhibits cell survival, affects cell survival additively in combination with irradiation and decreases clonogenic survival in both cell lines when applied alone.
CONCLUSION:
Betulinic acid could be a promising treatment agent in radioresistant head and neck cancer. A combination of betulinic acid with radiotherapy seems to be beneficial.
AuthorsChristina Eder-Czembirek, Boban M Erovic, Cornelia Czembirek, Markus Brunner, Edgar Selzer, Richard Pötter, Dietmar Thurnher
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 186 Issue 3 Pg. 143-8 (Mar 2010) ISSN: 1439-099X [Electronic] Germany
PMID20339825 (Publication Type: Journal Article)
Chemical References
  • Pentacyclic Triterpenes
  • Radiation-Sensitizing Agents
  • Triterpenes
  • Betulinic Acid
Topics
  • Carcinoma, Squamous Cell (pathology, radiotherapy)
  • Cell Line
  • Cell Survival
  • Dose-Response Relationship, Drug
  • Head and Neck Neoplasms (pathology, radiotherapy)
  • Humans
  • Pentacyclic Triterpenes
  • Radiation-Sensitizing Agents
  • Radiotherapy Dosage
  • Treatment Outcome
  • Triterpenes (administration & dosage)
  • Betulinic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: